1. Home
  2. BRR vs CCCC Comparison

BRR vs CCCC Comparison

Compare BRR & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BRR

Columbus Circle Capital Corp I Class A Ordinary Shares

HOLD

Current Price

$2.01

Market Cap

159.1M

Sector

Finance

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.91

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRR
CCCC
Founded
2024
2015
Country
United States
United States
Employees
5
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.1M
185.1M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BRR
CCCC
Price
$2.01
$2.91
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$12.20
AVG Volume (30 Days)
915.7K
2.4M
Earning Date
06-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.45
EPS
N/A
N/A
Revenue
N/A
$35,947,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.02
52 Week Low
$1.77
$1.20
52 Week High
$10.51
$3.82

Technical Indicators

Market Signals
Indicator
BRR
CCCC
Relative Strength Index (RSI) 42.60 55.72
Support Level $1.83 $2.30
Resistance Level $3.01 $3.82
Average True Range (ATR) 0.18 0.23
MACD 0.01 0.01
Stochastic Oscillator 54.76 82.64

Price Performance

Historical Comparison
BRR
CCCC

About BRR Columbus Circle Capital Corp I Class A Ordinary Shares

ProCap Financial Inc is focused on Bitcoin-focused media products and Bitcoin holdings. The Company typically provides advertising and marketing services through weekly digital media placements, including audio and social media advertisements. The Company offers media products to help independent investors understand financial markets, current events, and technology advancements. These media products include social media accounts, email newsletters, and audio or video content. The Company also added strategies related to the use of AI and automation to support the development and delivery of financial products and services.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: